NPPA demand notices impose Rs 1.77 crore penalty for alleged drug overcharging

Regulatory & Legal View source PDF Explain this filing

UNICHEMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹493.40

prior close

₹493.40

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-1.2% vs market

Pharmaceuticals peers, median of 154sector-0.3%-1.2% vs sector

On the reaction day the stock moved 1.2 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.7

15m

-1.2

30m

-1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5-0.3-1.2-0.3-1.2

Next day

-3.6-0.5-3.0-0.8-2.8

-5.2-0.8-4.4-1.1-4.1

-0.9-0.6-0.3-0.4-0.5

-2.5+0.1-2.6-0.1-2.4

-3.2-0.5-2.8-0.8-2.4

-5.3-0.6-4.7-1.3-4.0

15d

-5.0+1.3-6.2-1.5-3.5

-4.3-0.2-4.1-1.9-2.4

-9.8-6.8-3.0-6.1-3.7

-12.6-3.4-9.2-5.3-7.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

India's National Pharmaceutical Pricing Authority issued three demand notices on September 29, 2025, seeking a total penalty of Rs 1.77 crore for alleged overcharging of three drugs under the Drug Price Control Order. Unichem received them October 3. The periods cited run from 2013 to 2018. It sold its domestic formulation business in December 2017, sees no material financial or operational impact, and is evaluating legal options.

Likely market impact

Unichem expects no material financial or operational impact and is considering legal options, but the demand may weigh on sentiment until resolved.